MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PSNL made $15,472K in revenue. -$30,032K in net income. Net profit margin of -194.11%.

Income Overview

Revenue
$15,472K
Net Income
-$30,032K
Net Profit Margin
-194.11%
EPS
-$0.29
Unit: Thousand (K) dollars
Revenue Breakdown
    • Pharma Testing Services
    • Population Sequencing
    • Clinical Diagnostic
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
15,472 17,345 14,495 17,203
Cost of revenue
15,191 15,445 12,581 12,447
Research and development
14,539 13,072 12,171 12,381
Selling, general and administrative
17,903 14,094 13,034 14,179
Total costs and expenses
47,633 42,611 37,786 39,007
Loss from operations
-32,161 -25,266 -23,291 -21,804
Interest income
2,172 1,570 1,680 1,878
Interest expense
47 65 64 48
Other income (expense), net
20 -42 26 -80
Loss before income taxes
-30,016 -23,803 -21,649 -20,054
Provision for income taxes
16 9 3 2
Net loss
-30,032 -23,812 -21,652 -20,056
Basic EPS
-0.29 -0.258 -0.24 -0.23
Diluted EPS
-0.29 -0.258 -0.24 -0.23
Basic Average Shares
104,191,862 92,281,226 88,699,131 88,517,498
Diluted Average Shares
104,191,862 92,281,226 88,699,131 88,517,498
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$30,032K (-90.68%↓ Y/Y)Loss before incometaxes-$30,016K (-90.66%↓ Y/Y)Provision for income taxes$16K (128.57%↑ Y/Y)Interest income$2,172K (7.15%↑ Y/Y)Pharma TestingServices$10,724K Population Sequencing$2,500K (-40.66%↓ Y/Y)Clinical Diagnostic$1,431K (364.61%↑ Y/Y)Other$424K (1596.00%↑ Y/Y)Enterprise Sales$393K (-84.06%↓ Y/Y)Other income(expense), net$20K (143.48%↑ Y/Y)Loss from operations-$32,161K (-81.74%↓ Y/Y)Revenue$15,472K (-24.91%↓ Y/Y)Interest expense$47K (67.86%↑ Y/Y)Total costs andexpenses$47,633K (24.36%↑ Y/Y)Selling, general andadministrative$17,903K (45.99%↑ Y/Y)Cost of revenue$15,191K (13.38%↑ Y/Y)Research and development$14,539K (15.02%↑ Y/Y)

Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL)